[
    {
        "other_ids": [
            {
                "name": "Study Protocol Other Identifier",
                "value": "2019-002491-14"
            }
        ],
        "amendment_date": null,
        "keywords": null,
        "dcp_id": null,
        "interventional_model": "Parallel",
        "lead_org": "Hoffmann-La Roche",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Participants with a first diagnosis of HCC who have undergone either a curative resection or ablation (radiofrequency ablation [RFA] or microwave ablation [MVA] only) within 4-12 weeks prior to randomization"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "Documented diagnosis of HCC that has been completely resected or ablated (RFA or MVA only)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "Absence of major macrovascular invasion (except Vp1/Vp2) and extrahepatic spread"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "Absence of extrahepatic spread as confirmed by CT or MRI scan of the chest, abdomen, pelvis, and head prior to and following curative procedure"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "Full recovery from surgical resection or ablation within 4 weeks prior to randomization"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 5,
                    "description": "High risk for HCC recurrence after resection or ablation"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 6,
                    "description": "For patients who received post-operative transarterial chemoembolization: full recovery from the procedure within 4 weeks prior to randomization"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 7,
                    "description": "For patients with resected HCC, availability of a representative baseline tumor tissue sample"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 8,
                    "description": "ECOG Performance Status of 0 or 1"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 9,
                    "description": "Child-Pugh Class A status"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 10,
                    "description": "Adequate hematologic and end-organ function"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 11,
                    "description": "For women of childbearing potential: agreement to remain abstinent (refrain from heterosexual intercourse) or use contraceptive methods"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 12,
                    "description": "For men: agreement to remain abstinent (refrain from heterosexual intercourse) or use a condom, and agreement to refrain from donating sperm"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 13,
                    "description": "Known fibrolamellar HCC, sarcomatoid HCC, or mixed cholangiocarcinoma and HCC"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 14,
                    "description": "Evidence of residual, recurrent, or metastatic disease at randomization"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 15,
                    "description": "Clinically significant ascites"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 16,
                    "description": "History of hepatic encephalopathy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 17,
                    "description": "Prior bleeding event due to untreated or incompletely treated esophageal and/or gastric varices within 6 months prior to randomization"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 18,
                    "description": "Have received more than 1 cycle of adjuvant TACE following surgical resection"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 19,
                    "description": "Active or history of autoimmune disease or immune deficiency"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 20,
                    "description": "History of idiopathic pulmonary fibrosis, organizing pneumonia, drug-induced pneumonitis, or idiopathic pneumonitis, or evidence of active pneumonitis on screening chest CT scan"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 21,
                    "description": "Significant cardiovascular disease within 3 months prior to Day 1 of Cycle 1, unstable arrhythmia, or unstable angina"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 22,
                    "description": "History of malignancy other than HCC within 5 years prior to screening, with the exception of malignancies with a negligible risk of metastasis or death"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 23,
                    "description": "Active tuberculosis"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 24,
                    "description": "Any other disease, metabolic dysfunction, physical examination finding, or clinical laboratory finding that contraindicates the use of an investigational drug, may affect the interpretation of the results, or may render the patient at high risk from treatment complications"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 25,
                    "description": "Pregnant or breastfeeding, or intending to become pregnant during the study or within 5 months after the final dose of atezolizumab or within 6 months after the final dose of bevacizumab. Women of childbearing potential must have a negative serum pregnancy test result within 14 days prior to Day 1 of Cycle 1."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 26,
                    "description": "Co-infection with HBV and HCV"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 27,
                    "description": "Co-infection with HBV and hepatitis D viral infection"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 28,
                    "description": "Clinical significant uncontrolled or symptomatic hypercalcemia"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 29,
                    "description": "Any treatment for HCC prior to resection or ablation, including systemic therapy and locoregional therapy such as TACE"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 30,
                    "description": "Treatment with systemic immunostimulatory or immunosuppressive agents"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 31,
                    "description": "Inadequately controlled arterial hypertension"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 32,
                    "description": "History of hypertensive crisis or hypertensive encephalopathy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 33,
                    "description": "Significant vascular disease"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 34,
                    "description": "Evidence of bleeding diathesis or significant coagulopathy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 35,
                    "description": "Current or recent use of aspirin or full-dose oral or parenteral anticoagulants"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 36,
                    "description": "Core biopsy within 3 days of Day 1 of Cycle 1"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 37,
                    "description": "History of GI fistula, GI perforation, or intra-abdominal abscess"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 38,
                    "description": "Serious non-healing or dehiscing wound"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 39,
                    "description": "Major surgical procedure within four weeks"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 40,
                    "description": "Chronic daily treatment with a non-steroidal anti-inflammatory drug"
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": null,
        "official_title": "A Phase III, Multicenter, Randomized, Open-Label Study of Atezolizumab (Anti-PD-L1 Antibody) Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation",
        "_phase_sort_order": 0,
        "collaborators": [],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "Prior to any drug administration on Day 1 of Cycles 1, 2, 3, 4, 8, 12, and 16 (each cycle is 21 days)",
                "name": "Number of Participants with Anti-Drug Antibodies (ADAs) to Atezolizumab",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline to 24 and 36 months",
                "name": "OS Rate at 24 and 36 Months",
                "description": "OS rate defined as the proportion of patients who have not experienced death from any cause at 24 and 36 months after randomization.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline up to approximately 91 months",
                "name": "Overall Survival (OS)",
                "description": "OS is defined as the time from randomization to death from any cause.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline up to approximately 91 months",
                "name": "Percentage of Participants With Adverse Events",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline up to approximately 39 months",
                "name": "Recurrence-Free Survival (RFS), as Determined by IRF",
                "description": "RFS is defined as the time from randomization to the first documented occurrence of intrahepatic or extrahepatic HCC as determined by an IRF, or death from any cause (whichever occurs first).",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Baseline up to approximately 91 months",
                "name": "RFS as Determined by the Investigator",
                "description": "RFS is defined as the time from randomization to the first documented occurrence of intrahepatic or extrahepatic HCC as determined by an investigator, or death from any cause (whichever occurs first).",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline up to approximately 91 months",
                "name": "RFS in Pd-L1-High Subgroup",
                "description": "RFS after randomization as determined by the investigator and by an IRF, among patients in the PD-L1-high subgroup.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Randomization up to 24 months and up to 36 months",
                "name": "RFS Rate at 24 and 36 Months, as Assessed by the Investigator",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Randomization up to 24 months and up to 36 months",
                "name": "RFS Rate at 24 and 36 Months, as Assessed by the IRF",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Prior to any drug administration on Day 1 of Cycles 1, 2, 3, 4, 8, 12, and 16 (each cycle is 21 days)",
                "name": "Serum Concentration of Atezolizumab",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline up to approximately 91 months",
                "name": "Time to Extrahepatic Spread (EHS) or Macrovascular Invasion",
                "description": "Time to EHS or macrovascular invasion after randomization, defined as the time from randomization to the first appearance of EHS or macrovascular invasion, as determined by the investigator.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline up to approximately 91 months",
                "name": "Time to Recurrence (TTR)",
                "description": "TTR defined as the time from randomization to first documented occurrence of intrahepatic or extrahepatic HCC, as determined by the investigator and by an IRF.",
                "type_code": "SECONDARY"
            }
        ],
        "phase": "III",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 2,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT04102098",
        "biomarkers": [],
        "classification_code": null,
        "current_trial_status_date": "2022-01-05",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "CARCINOMA, HEPATOCELLULAR, MALIGNANT",
                    "Hepatocellular Carcinoma",
                    "Carcinoma of the Liver Cells",
                    "Liver Cell Carcinoma",
                    "LIHC",
                    "Carcinoma of Liver Cells",
                    "HCC",
                    "Hepatoma",
                    "Primary Carcinoma of the Liver Cells",
                    "Primary Carcinoma of Liver Cells",
                    "Liver Cell Cancer (Hepatocellular Carcinoma)"
                ],
                "nci_thesaurus_concept_id": "C3099",
                "name": "Hepatocellular Cancer",
                "type": [
                    "maintype",
                    "subtype"
                ],
                "parents": [
                    "C2852",
                    "C7927"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Relapsed Carcinoma of Liver Cell",
                    "Recurrent Liver Cell Carcinoma",
                    "Relapsed Carcinoma of the Liver Cell",
                    "Recurrent Carcinoma of the Liver Cell",
                    "Recurrent Carcinoma of Liver Cell",
                    "Recurrent Hepatoma",
                    "Relapsed Hepatocellular Carcinoma",
                    "Relapsed Liver Cell Carcinoma",
                    "Recurrent Hepatocellular Carcinoma",
                    "Relapsed Hepatoma",
                    "Hepatocellular Carcinoma, Recurrent"
                ],
                "nci_thesaurus_concept_id": "C9264",
                "name": "Recurrent Hepatocellular Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C3099",
                    "C7110",
                    "C159565",
                    "C131500"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Malignant Epithelial Neoplasm",
                    "Epithelial Carcinoma",
                    "Malignant Epithelioma",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Epithelial tumor, malignant",
                    "Epithelioma Malignant"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C3709",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Liver and Biliary System Disorder",
                    "Liver and Biliary Disease",
                    "Liver and Biliary Disorder",
                    "Liver Disease"
                ],
                "nci_thesaurus_concept_id": "C3959",
                "name": "Hepatobiliary Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2990"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Disease",
                    "Diseases and Disorders",
                    "disease type",
                    "Disease or Disorder",
                    "Diagnosis",
                    "disease_term",
                    "condition",
                    "disease_type",
                    "Diseases",
                    "Disease or Disorder, Non-Neoplastic",
                    "Disorders",
                    "Disorder"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasms, NOS",
                    "Neoplasia",
                    "Tumor, NOS",
                    "Neoplastic Growth",
                    "Neoplasm",
                    "Neoplastic Disease",
                    "tumor",
                    "Neoplasm, NOS"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Glandular Cell Epithelium Neoplasm",
                    "Glandular Cell Epithelial Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C7132",
                "name": "Glandular Cell Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Gastrointestinal System Disorder",
                    "Unspecified Gastrointestinal Problem",
                    "Disorder of Digestive System",
                    "stomach or intestinal disorder",
                    "GI Disorder",
                    "Gastrointestinal Disorder",
                    "Digestive System Disease",
                    "Gastrointestinal System Disease",
                    "Digestive Disease"
                ],
                "nci_thesaurus_concept_id": "C2990",
                "name": "Digestive System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Gastrointestinal System Neoplasm",
                    "Gastrointestinal cancer, NOS",
                    "Gastrointestinal System Cancer",
                    "Malignant Digestive System Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C4890",
                "name": "Malignant Gastrointestinal Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C3052"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Liver Disorder",
                    "Liver Disease",
                    "Hepatic Disorder"
                ],
                "nci_thesaurus_concept_id": "C3196",
                "name": "Liver and Intrahepatic Bile Duct Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3959"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor of GI System",
                    "Tumor of Digestive System",
                    "Digestive Tumor",
                    "GI Neoplasm",
                    "Neoplasm of the Gastrointestinal System",
                    "Digestive System Tumor",
                    "Gastrointestinal Tumor",
                    "Neoplasm of the Digestive System",
                    "Tumor of the Gastrointestinal System",
                    "Neoplasm of Digestive System",
                    "Tumor of the Digestive System",
                    "Gastrointestinal System Tumor",
                    "Gastrointestinal Neoplasm",
                    "GI Tumor",
                    "Tumor of Gastrointestinal System",
                    "Gastrointestinal System Neoplasm",
                    "Neoplasm of the GI System",
                    "GI System Tumor",
                    "GI System Neoplasm",
                    "Neoplasm of Gastrointestinal System",
                    "Tumor of the GI System",
                    "Digestive Neoplasm",
                    "Neoplasm of GI System"
                ],
                "nci_thesaurus_concept_id": "C3052",
                "name": "Digestive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3263",
                    "C2990"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Hepatic and Intrahepatic Bile Duct Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C7103",
                "name": "Liver and Intrahepatic Bile Duct Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3196",
                    "C8614"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Primary Malignant Neoplasm of Liver"
                ],
                "nci_thesaurus_concept_id": "C34803",
                "name": "Primary Malignant Liver Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8609",
                    "C7103"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Cancer of the Liver",
                    "Liver Carcinoma",
                    "Liver/hepatobiliary cancer",
                    "Cancer of Liver",
                    "Liver and hepatobiliary cancer, NOS",
                    "Liver and Intrahepatic Biliary Tract Cancer",
                    "Cancer of the Liver and Intrahepatic Biliary Tract",
                    "Liver and Intrahepatic Bile Duct Carcinoma",
                    "Liver and Intrahepatic Bile Duct Cancer",
                    "Cancer of Liver and Intrahepatic Biliary Tract",
                    "Liver and Intrahepatic Biliary Tract Carcinoma",
                    "Biliary Tract Cancer",
                    "Primary Liver Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C7927",
                "name": "Liver Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C34803",
                    "C7106",
                    "C96963"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor Morphology",
                    "Tumor_Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Adenocarcinoma, NOS",
                    "ADENOCARCINOMA, MALIGNANT"
                ],
                "nci_thesaurus_concept_id": "C2852",
                "name": "Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C7132"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Carcinoma of the Gastrointestinal System",
                    "Gastrointestinal System Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C96963",
                "name": "Digestive System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C4890"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Epithelial Hepatic and Intrahepatic Bile Duct Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C7106",
                "name": "Liver and Intrahepatic Bile Duct Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7103"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Liver and Biliary System Neoplasm",
                    "Malignant Liver and Biliary Neoplasm",
                    "Malignant Hepato-Biliary Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C8609",
                "name": "Malignant Hepatobiliary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4890",
                    "C8614"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Hepatic and Biliary Neoplasms",
                    "Hepato-Biliary Neoplasm",
                    "Liver and Biliary Neoplasm",
                    "Hepato-Biliary Tumor",
                    "Liver and Biliary System Neoplasm",
                    "Hepatic, Biliary, and Gallbladder Neoplasms",
                    "Hepatic and Biliary Tumors",
                    "Hepatobiliary Tumors",
                    "Hepatobiliary Tumor"
                ],
                "nci_thesaurus_concept_id": "C8614",
                "name": "Hepatobiliary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3052",
                    "C3959"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Malignant Growth",
                    "Tumor, malignant, NOS",
                    "Malignant Tumor",
                    "Malignancy",
                    "CA",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrent Primary Malignancy"
                ],
                "nci_thesaurus_concept_id": "C131500",
                "name": "Recurrent Primary Malignant Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4813"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Relapsed Cancer of the Liver",
                    "Relapsed Liver Cancer",
                    "Recurrent Liver Carcinoma",
                    "Relapsed Cancer of Liver",
                    "Recurrent Cancer of Liver",
                    "Recurrent Cancer of the Liver"
                ],
                "nci_thesaurus_concept_id": "C7110",
                "name": "Recurrent Liver Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7927",
                    "C7622"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrence",
                    "Recurrent Cancer",
                    "Recurrent Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C4813",
                "name": "Recurrent Malignant Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C9305",
                    "C4798"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrent Cancer",
                    "Relapsed Carcinoma",
                    "Relapsed Cancer"
                ],
                "nci_thesaurus_concept_id": "C7619",
                "name": "Recurrent Carcinoma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4813",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrence",
                    "Recurrent",
                    "Recurrent Tumor",
                    "Neoplasm Recurrence"
                ],
                "nci_thesaurus_concept_id": "C4798",
                "name": "Recurrent Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrent Gastrointestinal System Carcinoma",
                    "Recurrent Gastrointestinal System Cancer"
                ],
                "nci_thesaurus_concept_id": "C7622",
                "name": "Recurrent Digestive System Carcinoma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C96963",
                    "C7619"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C159565",
                "name": "Recurrent Adenocarcinoma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C2852",
                    "C7619"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "WO41535",
        "active_sites_count": 4,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [],
                "name": "Arm A (atezolizumab plus bevacizumab)",
                "description": "Participants will receive Atezolizumab + Bevacizumab until disease recurrence or unacceptable toxicity.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Arm B (active surveillance)",
                "description": "Active surveillance of participants.",
                "type": "NO_INTERVENTION"
            },
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immune Mediators",
                            "Immunomodulatory Agent",
                            "Immunomodulating Agent",
                            "Biological Response Modifier",
                            "BRM",
                            "Immunopotentiators",
                            "Biomodulators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapy Agent",
                            "Immunotherapeutic Agent",
                            "Immune Modulators"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-tumor Targeted Therapy Agent",
                            "Targeted Therapeutic Agent",
                            "Molecularly Targeted Therapy Agent",
                            "Targeted Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C128057",
                        "name": "Anti-PD-L1 Monoclonal Antibody",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C156893",
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "PD-1 Ligand-targeting Agent",
                            "PD-1 Ligands Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C156893",
                        "name": "PD-1 Ligand Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C143250"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Drug",
                            "Pharmacologic Agent",
                            "Pharmaceuticals",
                            "Pharmaceutical Agent",
                            "Agent",
                            "Drug Substance",
                            "Pharmacological Substance"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Mvasi",
                            "Zirabev",
                            "Avastin"
                        ],
                        "nci_thesaurus_concept_id": "C2039",
                        "name": "Bevacizumab",
                        "description": "A recombinant humanized monoclonal antibody directed against the vascular endothelial growth factor (VEGF), a pro-angiogenic cytokine.  Bevacizumab binds to VEGF and inhibits VEGF receptor binding, thereby preventing the growth and maintenance of tumor blood vessels. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C129822",
                            "C2496"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C141144",
                        "name": "Immune Checkpoint Modulator",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Ab",
                            "Anticancer Antibody",
                            "Anti-cancer Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C129822",
                        "name": "Antineoplastic Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C129821"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Biopharmaceuticals",
                            "Immunologic, Immunochemical",
                            "Biologicals",
                            "Immunologics",
                            "Biologics",
                            "Biological Products"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Biopharmaceuticals",
                            "Immunologic, Immunochemical",
                            "Biologicals",
                            "Immunologics",
                            "Biologics",
                            "Biological Products"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibody Anti-VEGF"
                        ],
                        "nci_thesaurus_concept_id": "C2496",
                        "name": "Anti-VEGF Monoclonal Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1742",
                            "C163758",
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibodies",
                            "Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C20401",
                        "name": "Monoclonal Antibody Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C307",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-tumor Targeted Therapy Agent",
                            "Targeted Therapeutic Agent",
                            "Molecularly Targeted Therapy Agent",
                            "Targeted Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antiangiogenic Agent",
                            "Antiangiogenesis Agents",
                            "Angiogenesis Antagonists",
                            "Angiogenesis Blockers",
                            "Anti-Angiogenic Agents"
                        ],
                        "nci_thesaurus_concept_id": "C1742",
                        "name": "Angiogenesis Inhibitor",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Biological",
                            "Antineoplastic Biotherapeutic",
                            "Anticancer Biological",
                            "Anti-cancer Biological Agent"
                        ],
                        "nci_thesaurus_concept_id": "C129821",
                        "name": "Antineoplastic Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibodies",
                            "Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C20401",
                        "name": "Monoclonal Antibody Therapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C307",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Tumor Agents",
                            "Antiproliferative Drugs",
                            "Cancer Drug",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antiproliferative Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Anti-Tumor Drugs",
                            "Anti-Cancer Agents",
                            "Antineoplastic Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Tumor Agents",
                            "Antiproliferative Drugs",
                            "Cancer Drug",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antiproliferative Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Anti-Tumor Drugs",
                            "Anti-Cancer Agents",
                            "Antineoplastic Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Drug",
                            "Pharmacologic Agent",
                            "Pharmaceuticals",
                            "Pharmaceutical Agent",
                            "Agent",
                            "Drug Substance",
                            "Pharmacological Substance"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Tecentriq"
                        ],
                        "nci_thesaurus_concept_id": "C106250",
                        "name": "Atezolizumab",
                        "description": "A human, Fc optimized, monoclonal antibody directed against the protein ligand PD-L1 (programmed cell death-1 ligand 1) with potential immunomodulating and antineoplastic activities. Anti-PD-L1 monoclonal antibody MPDL3280A binds to PD-L1, blocking its binding to and activation of its receptor, PD-1 (programmed death 1), which may enhance the T-cell-mediated immune response to neoplasms and reverse T-cell inactivation. In addition, by binding to PD-L1, MPDL3280A also prevents binding of this ligand to B7.1. PD-L1 is overexpressed on many human cancer cell types. PD-L1 binding to PD-1 on T-cells suppresses the immune system and results in increased immune evasion. PD-1, a transmembrane protein expressed on activated T-cells, is a negative regulator of the immune system that limits the expansion and survival of CD8+ T cells. The Fc region of MPDL3280A is modified in such a way that it does not induce either antibody-dependent cytotoxicity (ADCC) or complement-dependent cytotoxicity (CDC)",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C128057"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immune Mediators",
                            "Immunomodulatory Agent",
                            "Immunomodulating Agent",
                            "Biological Response Modifier",
                            "BRM",
                            "Immunopotentiators",
                            "Biomodulators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapy Agent",
                            "Immunotherapeutic Agent",
                            "Immune Modulators"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C143250",
                        "name": "Immune Checkpoint Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C141144"
                        ]
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2019-07238",
        "why_study_stopped": null,
        "brief_summary": "This study will evaluate the efficacy and safety of adjuvant therapy with atezolizumab plus\r\n      bevacizumab compared with active surveillance in participants with completely resected or\r\n      ablated hepatocellular carcinoma (HCC) who are at high risk for disease recurrence.",
        "brief_title": "A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation",
        "status_history": [
            {
                "status_date": "2022-01-05T00:00:00.000002",
                "status": "CLOSED_TO_ACCRUAL"
            },
            {
                "status_date": "2019-11-25T00:00:00.000001",
                "status": "ACTIVE"
            },
            {
                "status_date": "2019-10-14T00:00:00",
                "status": "IN_REVIEW"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 662,
        "_current_trial_status_sort_order": 7,
        "start_date": "2019-12-31",
        "record_verification_date": "2022-03-01",
        "ctep_id": null,
        "current_trial_status": "Closed to Accrual",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "Randomized Controlled Trial"
        },
        "acronym": "IMbrave050",
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Liver"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2027-07-16",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]